Clinical trial
A Phase I/II Trial of BMS-986253 in Myelodysplastic Syndromes
NCT05148234 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Trial of BMS-986253 in Myelodysplastic Syndromes
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- November 29, 2022
- Completion date
- July 3, 2023
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.